Bromocalcium Market Dynamics Intelligence, Analysis, and Forecast

I. Market Dynamics Intelligence
(A) Price Trends
1. Domestic Prices: As of May 2026, prices for domestic industrial-grade calcium bromide (≥90% purity) exhibit volatility. On April 21, 2026, the national average market price stood at RMB 26,000 per metric ton, a decline of RMB 3,000 per ton from the prior level. Prices vary significantly across different purity grades and packaging specifications. For instance, pharmaceutical-grade calcium bromide (≥99.5% purity) commands a substantially higher price, with quotations from certain manufacturers requiring direct negotiation; meanwhile, industrial-grade calcium bromide (≥92% purity) averaged RMB 5,820 per ton in the East China region in 2025—a year-on-year decrease of 3.1%. In contrast, pharmaceutical-grade calcium bromide (≥99.5% purity, compliant with USP/EP standards) averaged RMB 19,650 per ton in 2025, representing a year-on-year increase of 5.7%, thereby widening the price differential to RMB 13,830 per ton.
2. International Prices: In 2025, China’s export average price for calcium bromide rose by 5.4% year-on-year to USD 2,840 per ton, reflecting enhanced international recognition of high-quality domestically produced products.

(B) Supply-Demand Situation
1. Supply
– Production Capacity Distribution: As of 2025, China’s calcium bromide industry has formed an industrial cluster centered in Shandong, Jiangsu, Zhejiang, and Sichuan provinces. Shandong accounts for 42.3% of national capacity and hosts large-scale producers including Shandong Haihua Co., Ltd. and Shandong Tianli Pharmaceutical Co., Ltd.; Jiangsu contributes 28.7% of total capacity, represented by Jiangsu Anbang Chemical Co., Ltd. and Jiangsu Lanfeng Biochemical Co., Ltd.; Zhejiang and Sichuan collectively account for the remaining 29.0%, primarily supplied by Zhejiang Juhua Co., Ltd. and Sichuan Fuhua Tongda Agrochemical Technology Co., Ltd.
– Output Trends: National calcium bromide output in 2025 reached 86,000 metric tons, up 6.2% from 81,000 tons in 2024; alternative data suggest output reached 93,000 tons in 2025. Output of reagent-grade hydrated calcium bromide (≥99.5% purity) totaled 31,500 tons in 2025—representing 36.5% of total output.
2. Demand
– Domestic Demand: China’s calcium bromide market size reached RMB 1.03 billion in 2025, up 5.1% year-on-year. The oil and gas industry remains the largest end-use sector, accounting for approximately 30% of total demand. Although global energy transition is accelerating, continued demand from shale gas development and deepwater drilling sustains calcium bromide’s application in high-density drilling fluids. Additionally, calcium bromide finds use in mercury emission control at coal-fired power plants, pharmaceutical intermediates, refrigerants, flame retardants, and photosensitive materials. Demand in pharmaceutical and pesticide synthesis has risen due to supportive policy initiatives. In 2025, the share of premium pharmaceutical-grade products increased to 38.2%, up 3.7 percentage points from 34.5% in 2024—indicating a structural shift from basic industrial-grade toward high-value-added applications.
– Export Demand: In 2025, China exported 17,200 metric tons of calcium bromide, generating export revenue of RMB 208 million. Primary destinations included India, Brazil, the United States, and Southeast Asian countries. Exports to India reached 5,860 tons—34.1% of total exports—and grew 7.9% year-on-year; Indian buyers primarily utilize the product for drilling fluid formulation by domestic oilfield service companies.

(C) Industry Policies
1. Industrial Policies: The National Energy Administration’s “Unconventional Oil & Gas Development Action Plan (2025–2030)” sets a target annual shale gas production capacity of 35 billion cubic meters, directly driving an estimated average annual growth of ~8.2% in demand for fracturing-fluid calcium bromide. The Ministry of Ecology and Environment’s “2025 Catalogue of Green Alternatives for Brominated Chemicals” designates high-purity calcium bromide as a priority recommended reagent for pharmaceutical and pesticide synthesis, promoting higher shares of premium applications. In July 2025, the National Medical Products Administration officially implemented the “New Guidelines on Linked Review and Approval for Pharmaceutical Excipients”, accelerating GMP certification among calcium bromide powder manufacturers.
2. Environmental Regulations: Increasingly stringent environmental regulations globally are eliminating outdated production capacity and pushing the industry toward cleaner production and circular economy models; environmentally compliant products are projected to capture over 50% market share. The “Regulations on Safety Management of Hazardous Chemicals” impose binding constraints on manufacturing processes, raising compliance costs and accelerating the exit of backward capacity—prompting new capacity investments to concentrate in green-energy-rich regions such as Inner Mongolia and Xinjiang.

II. Analytical Assessment
(A) Price Trend Analysis
1. Short-Term Outlook: Recent declines in domestic industrial-grade calcium bromide prices may reflect adjustments in supply-demand balance, raw material cost fluctuations, or seasonal factors. Conversely, pharmaceutical-grade calcium bromide prices continue rising, indicating robust demand and relatively constrained supply for high-end products.
2. Long-Term Outlook: With sustained national support for unconventional oil & gas development and growing demand for high-purity calcium bromide in pharmaceutical and environmental applications, premium-grade product prices are expected to maintain an upward trajectory. Meanwhile, industrial-grade markets may face pricing pressure due to overcapacity—but as obsolete capacity exits and industry concentration rises, price volatility is likely to moderate gradually.

(B) Supply-Demand Structure Analysis
1. Supply Side: Industry concentration continues increasing, with leading enterprises gaining dominant positions via scale advantages, technological capabilities, and resource access. Going forward, firms possessing integrated salt-lake bromine extraction capabilities, mastery of low-temperature crystallization purification technologies, or closed-loop processes leveraging chlor-alkali by-product bromine resources will establish significant dual barriers—cost and quality—further expanding their market share.
2. Demand Side: Downstream demand from oil & gas exploration and pharmaceutical manufacturing will sustain growth, providing strong support for the calcium bromide market. In particular, rapid expansion in shale gas development and deepwater drilling will boost demand for high-density drilling fluid applications. Moreover, tightening environmental policies will broaden calcium bromide’s application scope—including mercury emission control at coal-fired power plants and inorganic synergistic flame-retardant additives—thereby further stimulating demand.

(C) Industry Trend Analysis
1. Industrial Structural Upgrading: The industry is transitioning from traditional chemical manufacturing toward high-end manufacturing and green economy sectors. Demand for premium pharmaceutical-grade and electronic-grade calcium bromide products is steadily rising, driving continuous optimization of product mix.
2. Technology Innovation-Driven Development: Applications of advanced technologies—including high-purity crystallization and separation, energy-coupled optimization and automated control of continuous reaction systems, and by-product recycling—will enhance product quality and production efficiency while lowering costs, fostering sustainable industry development.
3. International Expansion: As international recognition of high-quality Chinese calcium bromide products strengthens, export volumes are expected to grow further. Concurrently, domestic enterprises will deepen cooperation and exchanges with international markets to bolster global competitiveness.

III. Forecast
(A) Market Size Forecast
1. 2026 Outlook: China’s calcium bromide market size is projected to expand to RMB 1.09–1.37 billion in 2026, representing year-on-year growth of 5.8%–7.0%, slightly exceeding the 2025 growth rate. Key drivers include intensified deep-oil-and-gas exploration investments by Sinopec and CNPC in the Tarim and Sichuan Basins, and post-consistency-evaluation capacity ramp-up by leading pharmaceutical firms—including Hengrui Medicine, CSPC Zhendong, and Shijiazhuang Pharma Group—in bromine-based sedative generic drug manufacturing.
2. Five-Year Outlook (2026–2030): Under the baseline scenario, China’s calcium bromide market size is forecast to grow at a compound annual growth rate (CAGR) of approximately 6.4%, reaching over RMB 9.85 billion by 2030, with total demand projected to reach 101,200 metric tons.

(B) Price Trend Forecast
1. Premium Products: Prices for pharmaceutical-grade and electronic-grade calcium bromide are expected to continue rising, though the pace may gradually moderate amid intensifying competition and ongoing technological progress.
2. Industrial-Grade Products: Industrial-grade calcium bromide prices are likely to fluctuate at relatively low levels; however, with elimination of backward capacity and rising industry concentration, prices may stabilize and gradually recover.

(C) Supply-Demand Structure Forecast
1. Supply: Industry concentration is expected to further increase, with the CR5 (combined market share of top five enterprises) projected to rise from 41.3%–63.5% in 2025 to above 45.6% in 2026. New capacity additions will be concentrated among leading enterprises possessing resource, technological, and cost advantages—and will emphasize premium product lines.
2. Demand: Downstream demand for calcium bromide will continue growing, especially in oil & gas exploration, pharmaceutical manufacturing, and environmental protection sectors. Furthermore, continual expansion into emerging application areas will diversify calcium bromide demand patterns.